OR07-06 Once-Daily Oral Atumelnant (CRN04894) Induces Rapid, Substantial, and Sustained Reductions of Androstenedione and 17-Hydroxyprogesterone in Adults With Classical Congenital Adrenal Hyperplasia: Interim Results From a 12-Week, Phase 2, Open-Label Study
OR07-06 每日一次口服阿图美南特 (CRN04894) 可快速、显著且持续地降低经典型先天性肾上腺皮质增生症成人患者的雄烯二酮和 17-羟孕酮水平：一项为期 12 周的 II 期开放标签研究的中期结果
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-024-81316-y
Heidrich, Lara; Wiener, Julian; Castro-Camus, Enrique; Koch, Martin; Ornik, Jan; Srirangalingam, Umasuthan; Bruera, Dario; Ayala, Alejandro; Wu, Yang; De La Torre Ames, Eduardo; Krasner, Alan; Gadelha, Mônica R; Reisch, Nicole; Costa-Barbosa, Flavia Amanda; Nunes-Nogueira, Vania dos Santos; Auchus, Richard J; Bachega, Tania A S S
